Stebėti
Peter Fineran
Peter Fineran
Professor, Head of Phage-host interactions (Phi) laboratory,University of Otago, New Zealand
Patvirtintas el. paštas otago.ac.nz - Pagrindinis puslapis
Pavadinimas
Cituota
Cituota
Metai
A century of the phage: past, present and future
GPC Salmond, PC Fineran
Nature Reviews Microbiology 13 (12), 777-786, 2015
8202015
The phage abortive infection system, ToxIN, functions as a protein–RNA toxin–antitoxin pair
PC Fineran, TR Blower, IJ Foulds, DP Humphreys, KS Lilley, ...
Proceedings of the National Academy of Sciences 106 (3), 894-899, 2009
6612009
The arms race between bacteria and their phage foes
HG Hampton, BNJ Watson, PC Fineran
Nature 577 (7790), 327-336, 2020
6072020
The biosynthesis and regulation of bacterial prodiginines
NR Williamson, PC Fineran, FJ Leeper, GPC Salmond
Nature Reviews Microbiology 4 (12), 887-899, 2006
5832006
CRISPR-Cas: adapting to change
SA Jackson, RE McKenzie, RD Fagerlund, SN Kieper, PC Fineran, ...
Science 356 (6333), eaal5056, 2017
4062017
Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands
RB Vercoe, JT Chang, RL Dy, C Taylor, T Gristwood, JS Clulow, C Richter, ...
PLoS genetics 9 (4), e1003454, 2013
4022013
CRISPR–Cas systems: beyond adaptive immunity
ER Westra, A Buckling, PC Fineran
Nature Reviews Microbiology 12 (5), 317-326, 2014
3702014
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species
A Pawluk, RHJ Staals, C Taylor, BNJ Watson, S Saha, PC Fineran, ...
Nature microbiology 1 (8), 1-6, 2016
3522016
CRISPRTarget: bioinformatic prediction and analysis of crRNA targets
A Biswas, JN Gagnon, SJJ Brouns, PC Fineran, CM Brown
RNA biology 10 (5), 817-827, 2013
3432013
CRISPRDetect: a flexible algorithm to define CRISPR arrays
A Biswas, RHJ Staals, SE Morales, PC Fineran, CM Brown
BMC genomics 17, 1-14, 2016
3232016
Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information
PC Fineran, E Charpentier
Virology 434 (2), 202-209, 2012
3152012
Remarkable Mechanisms in Microbes to Resist Viral Infections
RL Dy, C Richter, GPC Salmond, PC Fineran
Annual Review of Virology 1 (1), 307-331, 2014
3102014
Degenerate target sites mediate rapid primed CRISPR adaptation
PC Fineran, MJH Gerritzen, M Suárez-Diez, T Künne, J Boekhorst, ...
Proceedings of the National Academy of Sciences 111 (16), E1629-E1638, 2014
3012014
A widespread bacteriophage abortive infection system functions through a Type IV toxin–antitoxin mechanism
RL Dy, R Przybilski, K Semeijn, GPC Salmond, PC Fineran
Nucleic acids research 42 (7), 4590-605, 2014
2962014
Anticancer and immunosuppressive properties of bacterial prodiginines
NR Williamson, PC Fineran, T Gristwood, SR Chawrai, FJ Leeper, ...
Future microbiology 2 (6), 605-618, 2007
2642007
Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) systems
C Richter, JT Chang, PC Fineran
Viruses 4 (10), 2291-2311, 2012
2552012
Priming in the Type IF CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer
C Richter, RL Dy, RE McKenzie, BNJ Watson, C Taylor, JT Chang, ...
Nucleic acids research 42 (13), 8516-8526, 2014
2242014
Global phylogeography and ancient evolution of the widespread human gut virus crAssphage
R Edwards, A Vega, H Norman, MC Ohaeri, K Levi, E Dinsdale, O Cinek, ...
Nature Microbiology, 2019
2192019
Quorum sensing controls adaptive immunity through the regulation of multiple CRISPR-Cas systems
AG Patterson, SA Jackson, C Taylor, GB Evans, GPC Salmond, ...
Molecular cell 64 (6), 1102-1108, 2016
2142016
Biotechnological exploitation of bacteriophage research
NK Petty, TJ Evans, PC Fineran, GPC Salmond
Trends in biotechnology 25 (1), 7-15, 2007
2032007
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20